193 related articles for article (PubMed ID: 24451126)
21. Effect of pH, temperature, and salt on the stability of Escherichia coli- and Chinese hamster ovary cell-derived IgG1 Fc.
Li CH; Narhi LO; Wen J; Dimitrova M; Wen ZQ; Li J; Pollastrini J; Nguyen X; Tsuruda T; Jiang Y
Biochemistry; 2012 Dec; 51(50):10056-65. PubMed ID: 23078371
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment.
Zeng F; Yang C; Gao X; Li X; Zhang Z; Gong R
J Biol Chem; 2018 Dec; 293(49):19127-19135. PubMed ID: 30327432
[TBL] [Abstract][Full Text] [Related]
23. Catabolism of the murine IgG1 molecule: evidence that both CH2-CH3 domain interfaces are required for persistence of IgG1 in the circulation of mice.
Kim JK; Tsen MF; Ghetie V; Ward ES
Scand J Immunol; 1994 Oct; 40(4):457-65. PubMed ID: 7939418
[TBL] [Abstract][Full Text] [Related]
24. Conformational Plasticity of the Immunoglobulin Fc Domain in Solution.
Remesh SG; Armstrong AA; Mahan AD; Luo J; Hammel M
Structure; 2018 Jul; 26(7):1007-1014.e2. PubMed ID: 29731233
[TBL] [Abstract][Full Text] [Related]
25. Structural determinants of unique properties of human IgG4-Fc.
Davies AM; Rispens T; Ooijevaar-de Heer P; Gould HJ; Jefferis R; Aalberse RC; Sutton BJ
J Mol Biol; 2014 Feb; 426(3):630-44. PubMed ID: 24211234
[TBL] [Abstract][Full Text] [Related]
26. Construction of pH-sensitive Her2-binding IgG1-Fc by directed evolution.
Traxlmayr MW; Lobner E; Hasenhindl C; Stadlmayr G; Oostenbrink C; Rüker F; Obinger C
Biotechnol J; 2014 Aug; 9(8):1013-22. PubMed ID: 24964247
[TBL] [Abstract][Full Text] [Related]
27. Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1.
Wu H; Truncali K; Ritchie J; Kroe-Barrett R; Singh S; Robinson AS; Roberts CJ
MAbs; 2015; 7(6):1072-83. PubMed ID: 26267255
[TBL] [Abstract][Full Text] [Related]
28. Structural consequences of aglycosylated IgG Fc variants evolved for FcγRI binding.
Ju MS; Na JH; Yu YG; Kim JY; Jeong C; Jung ST
Mol Immunol; 2015 Oct; 67(2 Pt B):350-6. PubMed ID: 26153451
[TBL] [Abstract][Full Text] [Related]
29. Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions.
Crispin M; Bowden TA; Coles CH; Harlos K; Aricescu AR; Harvey DJ; Stuart DI; Jones EY
J Mol Biol; 2009 Apr; 387(5):1061-6. PubMed ID: 19236877
[TBL] [Abstract][Full Text] [Related]
30. Effects of N-Glycan Composition on Structure and Dynamics of IgG1 Fc and Their Implications for Antibody Engineering.
Lee HS; Im W
Sci Rep; 2017 Oct; 7(1):12659. PubMed ID: 28978918
[TBL] [Abstract][Full Text] [Related]
31. Two-faced Fcab prevents polymerization with VEGF and reveals thermodynamics and the 2.15 Å crystal structure of the complex.
Lobner E; Humm AS; Mlynek G; Kubinger K; Kitzmüller M; Traxlmayr MW; Djinović-Carugo K; Obinger C
MAbs; 2017 Oct; 9(7):1088-1104. PubMed ID: 28816592
[TBL] [Abstract][Full Text] [Related]
32. Conformational and Colloidal Stabilities of Human Immunoglobulin G Fc and Its Cyclized Variant: Independent and Compensatory Participation of Domains in Aggregation of Multidomain Proteins.
Yageta S; Shibuya R; Imamura H; Honda S
Mol Pharm; 2017 Mar; 14(3):699-711. PubMed ID: 28186764
[TBL] [Abstract][Full Text] [Related]
33. Crystal structures of immunoglobulin Fc heterodimers reveal the molecular basis for heterodimer formation.
Choi HJ; Seok SH; Kim YJ; Seo MD; Kim YS
Mol Immunol; 2015 Jun; 65(2):377-83. PubMed ID: 25743157
[TBL] [Abstract][Full Text] [Related]
34. Contribution of variable domains to the stability of humanized IgG1 monoclonal antibodies.
Ionescu RM; Vlasak J; Price C; Kirchmeier M
J Pharm Sci; 2008 Apr; 97(4):1414-26. PubMed ID: 17721938
[TBL] [Abstract][Full Text] [Related]
35. An explorative study towards the chemical synthesis of the immunoglobulin G1 Fc CH3 domain.
Grassi L; Roschger C; Stanojlović V; Cabrele C
J Pept Sci; 2018 Dec; 24(12):e3126. PubMed ID: 30346065
[TBL] [Abstract][Full Text] [Related]
36. Structure of the murine unglycosylated IgG1 Fc fragment.
Feige MJ; Nath S; Catharino SR; Weinfurtner D; Steinbacher S; Buchner J
J Mol Biol; 2009 Aug; 391(3):599-608. PubMed ID: 19559712
[TBL] [Abstract][Full Text] [Related]
37. Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site-directed mutagenesis.
Kim JK; Tsen MF; Ghetie V; Ward ES
Eur J Immunol; 1994 Mar; 24(3):542-8. PubMed ID: 8125126
[TBL] [Abstract][Full Text] [Related]
38. C
Yageta S; Imamura H; Shibuya R; Honda S
MAbs; 2019 Apr; 11(3):453-462. PubMed ID: 30513259
[TBL] [Abstract][Full Text] [Related]
39. An "Fc-Silenced" IgG1 Format With Extended Half-Life Designed for Improved Stability.
Borrok MJ; Mody N; Lu X; Kuhn ML; Wu H; Dall'Acqua WF; Tsui P
J Pharm Sci; 2017 Apr; 106(4):1008-1017. PubMed ID: 28057542
[TBL] [Abstract][Full Text] [Related]
40. Generation and Characterization of an IgG4 Monomeric Fc Platform.
Shan L; Colazet M; Rosenthal KL; Yu XQ; Bee JS; Ferguson A; Damschroder MM; Wu H; Dall'Acqua WF; Tsui P; Oganesyan V
PLoS One; 2016; 11(8):e0160345. PubMed ID: 27479095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
